Catalyst Pharmaceuticals (CPRX) Capital Expenditures (QoQ) (2012 - 2026)
Catalyst Pharmaceuticals (CPRX) Capital Expenditures (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.63% |
| Dec 31, 2024 | -66.02% |
| Sep 30, 2024 | 2,490.00% |
| Jun 30, 2024 | -94.97% |
| Mar 31, 2024 | 113.98% |
| Dec 31, 2023 | 45.31% |
| Dec 31, 2021 | -39.71% |
| Sep 30, 2021 | 6,700.00% |
| Jun 30, 2021 | -99.89% |
| Jun 30, 2019 | 143.87% |
| Mar 31, 2019 | -90.09% |
| Dec 31, 2018 | 144.35% |
| Sep 30, 2018 | 94.82% |
| Dec 31, 2016 | 356,400.00% |
| Sep 30, 2015 | 1,176.55% |
| Jun 30, 2015 | -85.71% |
| Mar 31, 2015 | -43.08% |
| Dec 31, 2014 | 5.92% |
| Sep 30, 2014 | 0.90% |
| Jun 30, 2014 | -24.87% |